The global Veterinary/Animal Vaccinesmarket was valued at USD 6.04 billion in 2016 and is projected to reach USD 10.06billionby 2025, growing at a CAGR of 5.83% from 2017 to 2025.
In veterinary medicine, vaccination has proven to be a boon for animal health. Diseases such as canine parvovirus and canine distemper, feline leukemia, or equine tetanus, have been reduced and attempts are being made to expand the scope. The market under such circumstances is expected to grow during the forecast period.
Sample Infographics:
Market Dynamics:
1. Market Drivers
1.1 Increasing cases of livestock disease outbreaks
1.2 High Prevalence of Infectious diseases
1.3 Increase in usage of companion organisms
1.4 Increasing support from public and private sector
1.5 Technological Advancements in vaccine development
2. Market Restraints
2.1 High Cost of storage
Market Segmentation:
1. By Technology:
1.1 Live Attenuated Vaccines
1.2 Inactivated Vaccines
1.3 Toxoid Vaccines
1.4 Recombinant Vaccines
1.5 Other Vaccines
2. By Type:
2.1 Porcine Vaccines
2.2 Poultry Vaccines
2.3 Livestock Vaccines
2.3.1 Bovine
2.3.2 Small Ruminant
2.4 Companion animals vaccines
2.4.1 Canine
2.4.2 Feline
2.5 Aquaculture vaccines
2.6 Others
3. By Disease:
3.1 Porcine
3.2 Poultry
3.3 Livestock
3.3.1 Bovine
3.3.2 Small Ruminant
3.4 Companion animals
3.4.1 Canine
3.4.2 Feline
3.5 Aquaculture
3.6 Others
4. By Region:
4.1 North America (U.S., Canada, Mexico)
4.2 Europe (Germany, UK, France, Rest of Europe)
4.3 Asia Pacific (China, India, Japan, Rest of Asia Pacific)
4.4 Latin America (Brazil, Argentina, Rest of Latin America)
4.5 Middle East & Africa
Competitive Landscape:
The major players in the market are as follows:
1. Zoetis
2. Merck Animal Health
3. BoehringerIngelheim
4. Elanco
5. Ceva
6. Virbac
7. Vetoquinol
8. Phibro Animal Health
9. Hester
10. Hipra
11. IdtBiologika
12. Biogenesis Bago
13. Tianjin Ringpu
14. China Animal Husbandry
15. Jinyu Bio-Technology
These major players have adopted various organic as well as inorganic growth strategies such as mergers & acquisitions, new product launches, expansions, agreements, joint ventures, partnerships, and others to strengthen their position in this market.
RESEARCH METHODOLOGY OF VERIFIED MARKET INTELLIGENCE:
Research study on the Veterinary/Animal Vaccinesmarketwas performed in five phases which include Secondary research, Primary research, subject matter expert advice, quality check and final review.
The market data was analyzed and forecasted using market statistical and coherent models. Also market shares and key trends were taken into consideration while making the report. Apart from this, other data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Company Market Share Analysis, Standards of Measurement, Top to Bottom Analysis and Vendor Share Analysis.
To know more about the Research Methodology of Verified Market Intelligence and other aspects of the research study, kindly get in touch with our sales team.
1 INTRODUCTION OF GLOBAL VETERINARY/ANIMAL VACCINESMARKET
1.1 Overview of the Market
1.2 Scope of Report
1.3 Assumptions
2 EXECUTIVE SUMMARY
3 RESEARCH METHODOLOGY OF VERIFIED MARKET INTELLIGENCE
3.1 Data Mining
3.2 Validation
3.3 Primary Interviews
3.4 List of Data Sources
4 GLOBAL VETERINARY/ANIMAL VACCINESMARKETOUTLOOK
4.1 Overview
4.2 Market Dynamics
4.2.1 Drivers
4.2.2 Restraints
4.2.3 Opportunities
4.3 Porters Five Force Model
4.4 Value Chain Analysis
4.5 Regulatory Framework
5 GLOBAL VETERINARY/ANIMAL VACCINES MARKET, BY TECHNOLOGY
5.1 Live Attenuated Vaccines
5.2 Inactivated Vaccines
5.3 Toxoid Vaccines
5.4 Recombinant Vaccines
5.5 Other Vaccines
6 GLOBAL VETERINARY/ANIMAL VACCINES MARKET, BY TYPE
6.1 Porcine Vaccines
6.2 Poultry Vaccines
6.3 Livestock Vaccines
6.3.1 Bovine
6.3.2 Small Ruminant
6.4 Companion animals vaccines
6.4.1 Canine
6.4.2 Feline
6.5 Aquaculture vaccines
6.6 Others
7 GLOBAL VETERINARY/ANIMAL VACCINES MARKET, BY DISEASE
7.1 Porcine
7.2 Poultry
7.3 Livestock
7.3.1 Bovine
7.3.2 Small Ruminant
7.4 Companion animals
7.4.1 Canine
7.4.2 Feline
7.5 Aquaculture
7.6 Others
8 GLOBAL VETERINARY/ANIMAL VACCINESMARKET, BY GEOGRAPHY
8.1 Overview
8.2 North AmericaRegional Market Estimates and Forecasts, 2012 - 2025
8.2.1 U.S.
8.2.2 Canada
8.2.3 Mexico
8.3 EuropeRegional Market Estimates and Forecasts, 2012 - 2025
8.3.1 Germany
8.3.2 U.K.
8.3.3 France
8.3.4 Rest of Europe
8.4 Asia PacificRegional Market Estimates and Forecasts, 2012 - 2025
8.4.1 China
8.4.2 Japan
8.4.3 India
8.4.4 Rest of Asia Pacific
8.5 Latin AmericaRegional Market Estimates and Forecasts, 2012 - 2025
8.5.1 Brazil
8.5.2 Argentina
8.6 Rest of the WorldRegional Market Estimates and Forecasts, 2012 - 2025
9 GLOBAL VETERINARY/ANIMAL VACCINESMARKETCOMPETITIVE LANDSCAPE
9.1 Overview
9.2 Company Market Share
9.3 Vendor Landscape
9.4 Key Development Strategies
10 COMPANY PROFILES
10.1 Zoetis
10.1.1 Overview
10.1.2 Financial Performance
10.1.3 Product Outlook
10.1.4 Key Developments
10.2 Merck Animal Health
10.2.1 Overview
10.2.2 Financial Performance
10.2.3 Product Outlook
10.2.4 Key Developments
10.3 BoehringerIngelheim
10.3.1 Overview
10.3.2 Financial Performance
10.3.3 Product Outlook
10.3.4 Key Developments
10.4 Elanco
10.4.1 Overview
10.4.2 Financial Performance
10.4.3 Product Outlook
10.4.4 Key Developments
10.5 Ceva
10.5.1 Overview
10.5.2 Financial Performance
10.5.3 Product Outlook
10.5.4 Key Developments
10.6 Virbac
10.6.1 Overview
10.6.2 Financial Performance
10.6.3 Product Outlook
10.6.4 Key Developments
10.7 Vetoquinol
10.7.1 Overview
10.7.2 Financial Performance
10.7.3 Product Outlook
10.7.4 Key Developments
10.8 Phibro Animal Health
10.8.1 Overview
10.8.2 Financial Performance
10.8.3 Product Outlook
10.8.4 Key Developments
10.9 Hester
10.9.1 Overview
10.9.2 Financial Performance
10.9.3 Product Outlook
10.9.4 Key Development
10.10 Hipra
10.10.1 Overview
10.10.2 Financial Performance
10.10.3 Product Outlook
10.10.4 Key Development
10.11 IdtBiologika
10.11.1 Overview
10.11.2 Financial Performance
10.11.3 Product Outlook
10.11.4 Key Development
10.12 Biogenesis Bago
10.12.1 Overview
10.12.2 Financial Performance
10.12.3 Product Outlook
10.12.4 Key Development
10.13 Tianjin Ringpu
10.13.1 Overview
10.13.2 Financial Performance
10.13.3 Product Outlook
10.13.4 Key Development
10.14 China Animal Husbandry
10.14.1 Overview
10.14.2 Financial Performance
10.14.3 Product Outlook
10.14.4 Key Development
10.15 Jinyu Bio-Technology
10.15.1 Overview
10.15.2 Financial Performance
10.15.3 Product Outlook
10.15.4 Key Development
11 Appendix
11.1 Related Reports
The Animal Model Platform Market is set to witness immense growth during the forecast period 2024-2031. This intelligence report offers an in-depth analysis of the market size, share, growth, opportunity, competitive landscape, manufacturers...
Market Overview
The Asia Pacific Functional Proteins Market is projected to experience robust growth from 2024 to 2034, driven by increasing consumer awareness of health and wellness, along with the expanding applications of functional proteins across various industries. The market is e...
Market Overview
The Europe Functional Proteins Market is anticipated to witness significant growth from 2024 to 2034, driven by increasing health consciousness, rising demand for protein-enriched products, and expanding applications in the food and beverage industry. The market is proje...
Market Overview
The North America Functional Proteins Market is anticipated to witness substantial growth from 2024 to 2034, driven by the increasing consumer demand for health and wellness products, rising applications in food and dietary supplements, and advancements in protein extrac...
Market Overview
The Global Functional Proteins Market is anticipated to witness substantial growth over the next decade, driven by increasing consumer awareness of health and wellness, the rising demand for protein-rich diets, and expanding applications across various industries. As of ...
The Animal Gut Health Solutions Market is set to witness immense growth during the forecast period 2024-2031. This intelligence report offers an in-depth analysis of the market size, share, growth, opportunity, competitive landscape, manufac...
The Non-animal-sourced Alternative Proteins Market is set to witness immense growth during the forecast period 2024-2031. This intelligence report offers an in-depth analysis of the market size, share, growth, opportunity, competitive landsc...
The Veterinary Digital Pathology Market is set to witness immense growth during the forecast period 2024-2031. This intelligence report offers an in-depth analysis of the market size, share, growth, opportunity, competitive landscape, manufa...
The Companion Animal Diagnostics Imaging Market is set to witness immense growth during the forecast period 2024-2031. This intelligence report offers an in-depth analysis of the market size, share, growth, opportunity, competitive landscap...
The Animal Regenerative Medicine and Stem Cell Therapy Market is set to witness immense growth during the forecast period 2024-2031. This intelligence report offers an in-depth analysis of the market size, share, growth, opportunity, competi...